0001140361-19-018086.txt : 20191007
0001140361-19-018086.hdr.sgml : 20191007
20191007193313
ACCESSION NUMBER: 0001140361-19-018086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191007
FILED AS OF DATE: 20191007
DATE AS OF CHANGE: 20191007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seizinger Bernd R.
CENTRAL INDEX KEY: 0001789042
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141682
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER NAME:
FORMER CONFORMED NAME: Seizinger Bernd
DATE OF NAME CHANGE: 20190923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
form4.xml
FORM 4
X0306
4
2019-10-07
0001781983
Aprea Therapeutics, Inc.
APRE
0001789042
Seizinger Bernd R.
535 BOYLSTON STREET
BOSTON
MA
02116
true
Common Stock
2019-10-07
4
M
0
263970
0.07
A
263970
D
Stock Option (right to buy)
0.07
2019-10-07
4
M
0
263970
0
D
2025-09-04
Common Stock
263970
0
D
These options vested in connection with the completion of the Issuer's initial public offering.
/s/ Scott M. Coiante, attorney-in-fact
2019-10-07